Publications by authors named "Gerard Joberty"

25Publications

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Nat Chem Biol 2015 Mar 26;11(3):189-91. Epub 2015 Jan 26.

1] EpiNova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline,Medicines Research Centre, Stevenage, Hertfordshire, UK. [2] AstraZeneca, Oncology iMed, Cambridge Science Park, Cambridge, UK (R.J.S. and D.M.W.); Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA (D.J.S.); University of Massachussetts Medical School, Worcester, Massachusetts, USA (P.R.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nchembio.1735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397581PMC
March 2015

Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network.

J Biol Chem 2004 Mar 15;279(13):12804-11. Epub 2003 Dec 15.

Cellzome AG, Meyerhofstrasse 1, D-69117 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M312171200
Publisher Site
http://dx.doi.org/10.1074/jbc.M312171200DOI Listing
March 2004

Multiple splice variants of Par3 and of a novel related gene, Par3L, produce proteins with different binding properties.

Gene 2002 Jul;294(1-2):99-107

Center for Cell Signaling and Department of Pharmacology, University of Virginia Health Science Center, P.O. Box 800577, Charlottesville, VA 22908-0577, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-1119(02)00681-9DOI Listing
July 2002

Assembly of epithelial tight junctions is negatively regulated by Par6.

Curr Biol 2002 Feb;12(3):221-5

Center for Cell Signaling and Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908-0577, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-9822(01)00663-7DOI Listing
February 2002